Sanofi
Sanofi is a French healthcare company engaged in the research, development, manufacturing, and marketing of therapeutic healthcare solutions globally. The enterprise operates through three principal business segments: Biopharmaceuticals (encompassing specialty care and general medicines), Vaccines, and Consumer Healthcare. Its pharmaceutical product catalog includes specialty medicines such as Dupixent, diabetes treatments, oncology drugs, and pediatric combination vaccines. Revenue generation is driven by worldwide sales of patented prescription biopharmaceuticals and vaccines to healthcare distributors, pharmacies, and hospital systems. The corporation holds a leading global position in immunology, rare disease treatments, and human vaccine production. Sanofi is headquartered in Paris, France, and its shares are primary listed on Euronext Paris under ticker SAN, with American Depositary Receipts listed on the Nasdaq Stock Market.
125 of the funds FundTelligence covers report a position in Sanofi.
- Legal name
- Sanofi SA
- Sector
- Health Care
- Country
- France
- Funds holding it
- 125
Funds holding Sanofi
- BlackRock iShares MSCI Europe Health Care Sector UCITS ETF — BlackRock · 5.17 % (full portfolio disclosed, October 2026)
- Nordea Globale Stabile Aktier - Etisk tilvalg — Nordea Funds · 3.98 % (full portfolio disclosed, July 2026)
- DWS Invest CROCI Euro — DWS · 3.32 % (full portfolio disclosed, June 2026)
- Schroder ISF Global Sustainable Value — Schroders · 3.26 % (full portfolio disclosed, June 2026)
- DWS Invest CROCI Sectors Plus — DWS · 3.19 % (full portfolio disclosed, June 2026)
- DNB Health Care — DNB · 3.14 % (full portfolio disclosed, September 2026)
- Nordea Stabile Aktier — Nordea Funds · 3.13 % (full portfolio disclosed, July 2026)
- Nordea Globale Stabile Aktier — Nordea Funds · 3.13 % (full portfolio disclosed, July 2026)
Showing the 8 largest of 125 funds holding it.